Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States

Keyphrases

• All-male 10%
• Androgen Deprivation Therapy 100%
• Control Population 10%
• Gonadotropin-releasing Hormone 10%
• High Stage 10%
• Inappropriate Use 10%
• Incident Cancer 10%
• Low Risk 10%
• Low-risk Prostate Cancer 10%
• Medicare Beneficiaries 10%
• Medicare Data 10%
• Medicare Population 10%
• National Trends 10%
• Nested Logit Model 20%
• Non-cancer 10%
• Old Age 10%
• Primary Therapy 10%
• Prostate Cancer 100%
• Prostate Cancer Patients 10%
• Prostate-specific Antigen Level 10%
• Rapid Expansion 10%
• Reimbursement 10%
• Research Patterns 10%
• Surveillance Epidemiology 10%
• Therapy Utilization 10%
• United States 100%

Nursing and Health Professions

• Adjuvant 10%
• Androgen Deprivation Therapy 100%
• Epidemiology 10%
• Medicare 30%
• Prevalence 10%
• Prostate Cancer 100%
• Prostate Specific Antigen 10%
• Reimbursement 10%